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Aims: The present study aims to detect the effect of acanthoic acid (AA) on
alcohol exposure-induced liver lipid deposition and inflammation, and to explore the
mechanisms.
Methods: C57BL/6 mice were pretreated with single dose of AA (20 and 40 mg/kg)
by oral gavage or equal volume of saline, and then exposed to three doses of ethanol
(5 g/kg body weight, 25%, w/v) by gavage within 24 h. The mice were sacrificed at
6 h after the last ethanol dosing. Serum and hepatic indexes were detected by western
blot, RT-PCR, and histopathological assay. AML-12 cells were pretreated with AA (5,
10, 20 µM), or AICAR (500 µM), GW3965 (1 µM), SRT1720 (6 µM), Nicotinamide
(20 mM) for 2 h, respectively, and then following treated with EtOH (200 mM) and
lipopolysaccharide (LPS) (10 ng/ml) for additional 48 h. Cell protein and mRNA were
collected for western blot and RT-PCR. Cytokines interleukin-1β (IL-1β) and tumor
necrosis factor-α (TNF-α) release were detected by ELISA assay.
Results: It was found that AA significantly decreased acute ethanol-induced increasing
of the serum ALT/AST, LDH, ALP levels, and hepatic and serum triglyceride levels, and
reduced fat droplets accumulation in mice liver. AA significantly suppressed the levels of
sterol regulatory element binding protein 1 (SREBP-1), cytochrome P4502E1 (CYP2E1),
IL-1β, and caspase-1 induced by ethanol. Furthermore, a significant decline of sirtuin 1
(Sirt1) and liver X receptors (LXRs) levels was observed in EtOH group, compared with
normal group mice. And AA pretreatment increased the Sirt1 and LXRs levels, and also
ameliorated phosphorylation of liver kinase B-1 (LKB-1), adenosine monophosphate-
activated protein kinase (AMPK), acetyl CoA carboxylase (ACC) proteins, compared
with EtOH group. However, the levels of peroxisome proliferator activated receptor
-α or -γ (PPAR-α or PPAR-γ) induced by acute ethanol were reversed by AA. In
EtOH/LPS cultivated AML-12 cells, AA decreased IL-1β and TNF-α levels, lipid droplets,
and SREBP-1 and CYP2E1 expressions, compared with EtOH/LPS treatment. AA
also significantly increased protein expressions of Sirt1, p-LKB1, p-ACC, PPARα, and
decreased protein expression of PPARγ, compared with EtOH/LPS treatment.
Conclusion: Acanthoic acid can partially prevent alcohol exposure-induced liver
lipid deposition and inflammation via regulation of LKB1/Sirt1/AMPK/ACC and LXRs
pathways.
Keywords: acanthoic acid, alcohol, liver lipid deposition, inflammation, Sirt1, LXRs
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INTRODUCTION
Alcohol consumption is the single most important factor for
alcohol liver disease, and the latter is a major health problem
all over the world. Alcoholic liver diseases (ALD) include
simple fatty liver, steatosis or fibrosis, and more severe liver
injury such as alcoholic hepatitis, cirrhosis, and hepatocellular
carcinoma (Mathurin and Bataller, 2015; Addolorato et al., 2016).
It is investigated that ALD is liable for 5.9% global mortality,
5.5% global disease burden and 2.5 million deaths worldwide
(European Association for the Study of Liver, 2012; Dugum
and McCullough, 2015). Fatty liver is the earliest stage and
characterized by fat accumulation in hepatocytes. Some steatosis
even progress to steatohepatitis and accompany the persistence
of fatty liver and inflammation. In the later stage, collagen
deposition and regenerative nodules would result in fibrosis
and cirrhosis. Alcohol withdrawal is necessary to prevent the
development of ALD. And also seeking the mechanisms of
alcoholic liver damage may supply pharmacologic therapeutic
strategies to reduce disease progression.
The liver is the major organ of alcohol metabolism and a
main targeting tissue damaged by alcohol. Alcohol can induce
the increasing of TG and free fatty acid synthesis, slow down
the elimination of free fatty acid in hepatocytes, and break the
equilibrium of synthesis and secretion of TG, eventually lead to
excessive deposition of lipid in liver and form fatty liver. Another,
inflammatory reaction is also the most important reason of ALD.
Intestines intake alcohol and increase intestinal endotoxemia to
enter into blood by enterohepatic circulation, and then further
Abbreviation:ACC, Acetyl CoA carboxylase; ALP, alkaline phosphatase; ALT,
alanine aminotransferase; AMPK, adenosine monophosphate-activated protein
kinase; AST, aspartate aminotransferase; CYP2E1, Cytochrome P4502E1; IL-1β,
Interleukin-1β; LDH, lactate dehydrogenase; LKB-1, liver kinase B-1; LPS,
lipopolysaccharide; LXRs, liver X receptors; PPARα, peroxisome proliferator
activated receptor α; PPARγ, peroxisome proliferator activated receptor γ; SIRT1,
sirtuin 1; SREBP-1, sterol regulatory element binding protein 1; TG, triglyceride.
activate Kupffer cells to release inflammatory factors. Current
researches have indicated that alcohol and its metabolites play
important roles in the formation of alcoholic fatty liver through
hepatotoxicity, oxidative stress, lipid peroxidation, and ethanol
metabolic enzyme system. Although, the great development of
ALD has been performed in recent years, the precise mechanisms
are not well understood. In the current study, mice were exposed
to three doses of ethanol (5 g/kg) by gavage with 12 h intervals.
The acute ethanol mice model has been wildly used in many
references (Carson and Pruett, 1996; Izu et al., 2006; Kumar et al.,
2011; Chen et al., 2014). In order to elucidate the mechanism
in the pathogenesis of acute ethanol-induced liver damage, this
animal model was utilized for the evaluation in vivo. And the
acute ethanol exposure induced inflammation and significantly
increased LPS levels. Thus, ethanol was exposed to LPS-primed
AML-12 cells to mimic hepatocytes development during ALD
progression in vitro.
Sirtuin (silent mating type information regulation 2 homolog)
1 (Sirt1), a kind of nicotinamide (NAD+)-dependent protein
deacetylase, may control fatty acid homeostasis in liver. Study has
been done regarding in the partial absence of Sirt1 activity, even
normal diet also can increase liver steatosis in Sirt1+/−mice, and
possible mechanism is related with the increase of lipid synthesis
in the liver of Sirt1+/−mice (Xu et al., 2010). It was reported the
compounds from Acanthopanax upregulate Sirt1 gene expression
(Park et al., 2015). Therefore, we consider whether Acanthoic acid
(AA) has the same up-regulation effect on Sirt1.
Acanthoic acid (AA, (-)-primara-9(11), 15-dien-19-oic acid,
Figure 1A) is a pimarane-type diterpene extracted from
Acanthopanax koreanum Nakai (Araliaceae). This plant has been
classified as a unique species of the Acanthopanax genus, and
traditionally used in the treatment of rheumatism, diabetes,
and hepatitis (Jung et al., 2013). AA exhibits various biological
properties, including anti-inflammatory and antioxidant (Través
et al., 2014; Wei et al., 2015). Our previous studies have
indicated that AA shows a strong protective effect against
FIGURE 1 | Effects of acanthoic acid (AA) on the serum ALT/AST activities, the serum LDH, and ALP activities. (A) Chemical structure of AA; (B) Methods
of animals and ethanol treatment; (C) Serum ALT/AST activity; (D) serum LDH activity; (E) serum ALP activity. Data were presented as mean ± SD (n = 6).
#p < 0.05, ##p < 0.01,###p < 0.001 vs. normal group; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. EtOH group.
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drug-induced hepatotoxicity, and works as a LXRs agonist
regulating hepatic fibrosis in mice (Wu et al., 2010; Bai
et al., 2014). However, Sirt1 is a positive regulator of LXR
proteins. Subsequently, the present study aims to identify the
regulation effect of AA on alcohol exposure-induced liver lipid
deposition and inflammation, and elucidate the expression of
Sirt1 under AA treatment and the Sirt1 relative mechanism of AA
treatment on alcohol exposure-induced liver lipid deposition and
inflammation.
MATERIALS AND METHODS
Plant Material
Acanthopanax koreanum Nakai (Araliaceae) was afforded by
Yanbian University. A voucher specimen (YBUCP201001)
was deposited in the Herbarium of College of Pharmacy,
Yanbian University, China. AA was isolated from the roots
of Acanthopanax koreanum Nakai (Araliaceae) as described
previously (Kim et al., 1988; Bai et al., 2014), and obtained by a
preparative HPLC with a yield of 0.82% and purity >95%.
Animal Procedures
Male C57BL/6 mice (6-week-old; body weight 18–22 g) were
obtained from Changchun Yisi Laboratory Animal Technology
Co., Ltd (Jilin, People’s Republic of China) [SPF, SCXK (J) 2003-
0008]. And all mice were maintained in controlled environment
with temperature of 22 ± 2◦C, 50–60% of relative humidity and
a 12-h light, 12-h dark cycle per day during the experiment
period. The experiment procedures were approved by the
Institutional Animal Care and Use Committee of Yanbian
University (Resolution number, 201501021).
Mice were randomly separated into the following five groups:
normal group, AA-40 group, EtOH group, EtOH+AA-20 group,
EtOH+AA-40 group, each group six mice. AA administration
groups, including AA-40, EtOH+AA-20, EtOH+AA-40 groups,
were pretreated with single dose of AA (20 or 40 mg/kg
body weight, respectively) by oral gavage for 14 consecutive
days. At the same time, normal group and EtOH group were
administrated by gavage with equal volume of saline for 14
consecutive days. Following, except normal group and AA-40
group, other groups were exposed to three doses of ethanol
(5 g/kg body weight) by gavage within 24 h (Portari et al., 2016;
Yang et al., 2016). All animals were sacrificed at 6 h after the
last ethanol dosing and blood was taken from the carotid artery
of the mice by ether anesthesia (Figure 1B). The liver tissue
was fixed in 10% formalin or kept at −80◦C for subsequent
analysis.
Cell Culture and Treatment
AML-12 cell, an immortalized mouse hepatocyte, was generous
gifts from Professor by Dr. Jung Joon Lee of Korea Research
Institute of Bioscience and Biotechnology (Daejeon, Korea).
AML-12 was incubated in DMEM supplemented with 10%
fetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml
streptomycin at 37◦C under 5% CO2. The cultures were passaged
by trypsinization every 3 days and cells were plated in 100 mm
culture dishes at a density of 1 × 106 cells per dish in DMEM.
For the experiment, cells were pretreated with AA (5, 10,
20 µM), or AICAR (500 µM), or GW3965 (1 µM), or SRT1720
(6 µM), or Nicotinamide (20 mM) for 2 h, respectively, and then
following treated with EtOH (200 mM) and LPS (10 ng/ml) for
additional 48 h.
Serum Aminotransferase and
Triglyceride Measurement
The blood samples were separated by centrifugation at 3000 rpm
for 30 min at 4◦C and levels of ALT and AST of the blood
serums were measured using Arkraysp-4430 fully automatic
chemistry analyzer. The serum TG levels were measured by TGs
Assay kit.
Histopathological Assay
Liver tissue was fixed in 10% formalin solution and embedded
in paraffin and cut into 5 µm section. Then the sections were
deparaffinized with xylene and gradient ethanol dehydration.
Sections were stained with hematoxylin-eosin solution, and
dehydrated with gradient alcohol and xylene and sealed with
neutral gum. The histopathological sections were examined
under light microscopy and evaluated scores from 0 to 5
(0 = no lesions; 1 = minimal lesions; 2 = mild lesions;
3=moderate lesions; 4=marked lesions; and 5= severe lesions)
(Leung et al., 2013).
Immunohistochemistry Analysis
Sections were incubated with 5% Goat Serum for 30 min
in a humidified chamber at room temperature and blocking
with Antibody-Ms-mAb-to-SREBP-1 (Abcam, Cambridge, MA,
USA) at 37◦C for 3 h. Then the sections were incubated
with Biotin-SP-Conjugated Affinipure Fab Fragment Goat Anti-
Mouse IgG for 20 min at room temperature. HRP labeled
secondary antibody were incubated according to the steps
mentioned in the statement of the MaxVisionTM HRP-Polymer
anti-mouse/rabbit IHC kit (Maixin Biol, Fu Zhou, China). The
tissue slides were counterstained 10–15 s with hematoxylin,
dehydrated gradient alcohol and xylene, and sealed with neutral
gum in the end.
The immunohistochemical staining was analyzed with Image
Pro-Plus 6.0, expressed in mean optical density (MOD). Four
fields of vision without any overlap in each section were
selected randomly and photographed with 200 magnifications.
It was required to detect the area of valid measure-area by
software firstly, and then measured the integrated optic density
of targeting stain region in this area. The percent of integrated
optic density of the area was MOD (Wan et al., 2010).
Oil Red O Staining Analysis
Cultivated cell dishes were washed in deionized water and fixed
in ice-cold 60% isopropanol quickly, and then blocking with oil
red O solution for 10 min at room temperature, then washed with
deionized water and stained with hematoxylin. In the end, tissue
sections were sealed with glycerin gelatin. The oil red O staining
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was analyzed with Image Pro-Plus 6.0, expressed in MOD (Wan
et al., 2010).
Immunofluorescence Staining
The frozen sections were fixed in the ice-cold mixed liquor
of acetone and methanol, dried, dehydrated, and blocked by
5% goat serum. The sections were incubated with the primary
antibody against F4/80 (Abcam, Cambridge, MA, USA) at room
temperature for 2 h. Then, the sections were incubated with Alexa
Fluor Goat pAb to Rat IgG (Abcam, Cambridge, MA, USA) at
room temperature for 1 h. Incubated with DAPI, the sections
were visualized under microscope. The immunofluorescence
staining was analyzed with Image Pro-Plus 6.0, expressed in
MOD (Wan et al., 2010).
Western Blotting Analysis
Protein isolation and western blot analysis were performed
as described in literature (Wu et al., 2010). Briefly, protein
samples were placed in sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and blotted onto polyvinylidene difluoride
membranes. The membranes were blocking with non-fat dry
milk for 1 h and incubated at room temperature for 2 h
with p-LKB1, LKB1, p-AMPKα, AMPKα, p-AMPKβ, AMPKβ,
p-ACC, ACC (Cell Signaling Technology, Boston, MA, USA) or
SREBP-1, CYP2E1, GAPDH, Sirt1, PPARγ (Abcam, Cambridge,
MA, USA) or caspase-1, β-actin, PPARα (Santa Cruz, CA, USA)
or IL-1β (R&D Systems Europe Ltd., Abingdon, UK). Then the
membranes were followed by incubated with HRP-conjugated
secondary antibody for 1 h at room temperature and visualized
by ECL Prime Western Blotting Detection Reagent (Bio-Rad,
USA).
RT-PCR Assay
Total RNA was extracted from mouse liver tissues by Eastep total
RNA Extraction Kit (Beyotime Institute of Biotechnology, China)
according to the manufacturer’s protocol. cDNA was prepared
using 500 ng of total RNA, carried out on the ABI Veriti R©
Thermal Cyclers. The primer sequences used in PCR are shown in
Table 1. PCR products were run on a 2% agarose gel and ethidium
bromide. The mRNA expression level of endogenous GAPDH
TABLE 1 | The primer sequences for RT-PCR.
Target genes Primer sequences Product length (bp)
IL-1β 5′-TCTTTGAAGAAGAGCCCATCC-3′ 61
5′-CTAATGGGAACGTCACACAC-3′
SREBP-1 5′-CTTAGCCTCTACACCAACTG-3′ 246
5′-AGGAATACCCTCCTCATAGC-3′
IL-18 5′-GATCAAAGTGCCAGTGAACC-3′ 233
5′-AACTCCATCTTGTTGTGTCC-3′
LXRβ 5′-CACCATTGAGATCATGTTGC-3′ 309
5′-TTGATCCTCGTGTAGGAGAG-3′
LXRα 5′-CCTCTGGCTTCCATTACAAC-3′ 201
5′-CTTCTGACAGCACACACTC-3′
GAPDH 5′-ATGGTGAAGGTCGGTGTGAA-3′ 233
5′-CGCTCCTGGAAGATGGTGAT-3′
was used as an internal. The primer sequences used in PCR are
shown in Table 1.
Statistical Analyses
All data were expressed as the mean ± SD statistical differences.
Statistical analyses were performed using one-way analysis of
variance (ANOVA) and Tukey’s multiple comparison tests.
Statistically significant differences between groups were defined
as p < 0.05. Calculations were performed using GraphPad Prism
(GraphPad Software, San Diego, CA, USA).
RESULTS
AA Effectively Attenuated Alcohol
Exposure-Induced Fatty Liver
Mice were given ethanol (5 g/kg) in 24 h to simulate a binge
drinking. Acute ethanol challenge induced significant increase
of the serum ALT and AST activities, and also led to significant
increase of serum LDH and ALP, which present the same
clinical meaning with ALT/AST. And all these serum parameters
were suppressed by AA pretreatment (Figures 1C–E). And AA
pretreatment also reversed increased serum TG and hepatic TG
levels after acute ethanol challenge (Figures 2A,B). In consistent
with above parameters, acute ethanol challenge led to massive
steatosis in mice liver tissue, which was obviously alleviative in
AA pretreatment group suffering ethanol (Figures 2C,D). In the
liver section of ethanol group, red-stained lipid droplets were
observed in oil red staining. However, no obvious fat droplets
were observed in the liver section of AA pretreatment group
suffering ethanol (Figures 2C,E). These results indicate that AA
has hepatic protective effects against alcoholic liver injury after
binge drinking.
AA Pretreatment Suppressed SREBP-1
and CYP2E1 Activations Induced by
Ethanol
Sterol regulatory element binding protein 1 is an important
nuclear transcription factor involved in fatty acid synthesis,
which mediates lipogenesis pathway. To investigate the effect
of AA on SREBP-1, the protein and mRNA levels of SREBP-
1 were detected. As shown in Figures 3A,B, acute ethanol
challenge increased SERBP-1 protein and mRNA levels compared
to the normal mice. These changes were significantly reversed
by AA pretreatment. And no significant change of SREBP-1 was
observed in only AA pretreatment group. Immunohistochemical
detection of SREBP-1 levels also showed an increase by binge
ethanol treatment with brown positive stained (Figures 3C,D).
AA pretreatment decreased SREBP-1 positive expressions caused
by ethanol. And almost no positive stained in normal and only
AA groups. CYP2E1 is one central pathway in the ability of
ethanol to induced lipid peroxidation and oxidative stress. In
Figure 3A, CYP2E1 protein levels were increased after ethanol
challenge, and were significantly suppressed with AA (40 mg/kg)
pretreatment. AA pretreatment could attenuate binge ethanol-
induced oxidative stress via CYP2E1 suppression.
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FIGURE 2 | Effects of AA on the serum and hepatic TG levels and hepatic morphology. (A) Serum TG levels; (B) hepatic TG levels; (C) Hematoxylin and
Eosin (H&E) stain, and oil red O stain. HE was calculated histopathological scores (D) and Oil red O staining (E) was analyzed with Image Pro-Plus 6.0. Data were
presented as mean ± SD (n = 6). ###p < 0.001 vs. normal group; ∗p < 0.05, ∗∗∗p < 0.001 vs. EtOH group.
FIGURE 3 | Acanthoic acid pretreatment suppressed SREBP-1and CYP2E1 activations induced by ethanol. (A) Western blot analysis of SREBP-1 and
CYP2E1 protein expressions after ethanol challenge; (B) RT-PCR analysis of SREBP-1 mRNA expression after ethanol challenge; (C) Immunohistochemical staining
of SREBP-1 after ethanol challenge. (D) Immunohistochemical staining of SREBP-1 was analyzed with Image Pro-Plus 6.0. ###p < 0.001 vs. normal group;
∗∗∗p < 0.001 vs. EtOH group.
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FIGURE 4 | Acanthoic acid pretreatment ameliorated hepatic inflammation in acute alcohol exposure mice. (A) RT-PCR analysis of IL-1β and caspase-1
mRNA expressions after ethanol challenge; (B) Western blot analysis of IL-1β and caspase-1 protein expressions after ethanol challenge; (C) Immunofluorescence
staining analysis of F4/80 expression in the livers of mice. Immunofluorescence staining of F4/80 was analyzed with Image Pro-Plus 6.0. ###p < 0.001 vs. normal
group; ∗∗p < 0.01, ∗∗∗p < 0.001 vs. EtOH group.
AA Pretreatment Ameliorated Hepatic
Inflammation in Acute Alcohol Exposure
Mice
Liver immune cells, such as Kupffer cells, play a significant
role in ethanol challenge. Ethanol exposure stimulates gut to
release LPS, and then produce pro-inflammatory cytokines in
response to LPS. IL-1β, one of the major caspase-1 targets,
is a pro-inflammatory cytokine that is cleaved by caspase-1
to yield a 17 kDa mature form (Ghiringhelli et al., 2009).
With ethanol challenge, the IL-1β protein and mRNA levels
were significantly increased compared to that in the normal
group. The up-regulations of IL-1β were markedly inhibited
with AA pretreatment (Figures 4A,B). Caspase-1 regulates
the inflammatory response by promoting the processing and
release of inflammatory factors. AA pretreatment reversed
caspase-1 protein and mRNA levels that increased by ethanol
challenge (Figures 4A,B), which also demonstrated that AA
inhibited caspase-1 to block the processing and release of pro-
inflammation cytokines. Expressions of F4/80, a cell surface
glycoprotein and expressed in mature macrophages, in mice
liver were detected by immunofluorescence staining. The
expressions of F4/80 (green) were markedly observed in ethanol
group, and AA pretreatment decreased the F4/80 expressions
(Figure 4C). These results demonstrated that AA could suppress
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FIGURE 5 | Effects of AA and acute ethanol challenge on the Sirt1 pathway and the phosphorylation of LKB1, AMPK and ACC. (A) Representative
western blot analysis of Sirt1 in the cytoplasm and the nucleus was normalized based on the internal control β-actin or GAPDH; (B) Representative western blot
analysis of p-LKB1 and total LKB1; (C) Representative western blot analysis of p-AMPKα, p-AMPKβ, and total AMPKα and AMPKβ; (D) Representative western blot
analysis of p-ACC and total ACC. #p < 0.05, ##p < 0.01,###p < 0.001 vs. normal group; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. EtOH group.
FIGURE 6 | Effects of AA and acute ethanol challenge on the LXRs pathway, PPARα and PPARγ expressions. (A) RT-PCR analysis of LXRα and LXRβ was
normalized based on the internal control GAPDH; (B) Representative western blot analysis of PPARα and PPARγ was normalized based on the internal control
GAPDH. #p < 0.05, ###p < 0.001 vs. normal group; ∗∗p < 0.01, ∗∗∗p < 0.001 vs. EtOH group.
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FIGURE 7 | Acanthoic acid ameliorated lipid deposition and inflammation in EtOH/LPS stimulated AML-12 cells. (A) Cell viability of EtOH on AML-12.
(B) Cell viability of AA on AML-12; (C) Cell TG levels; (D) Cell IL-1β levels; (E) Cell TNF-α levels; (F) cell oil red O staining, and Oil red O staining was analyzed with
Image Pro-Plus 6.0; (G) Representative Western blot analysis of SREBP1 and CYP2E1 was normalized based on the internal control β-actin. ###p < 0.001 vs.
normal group; ∗∗p < 0.01, ∗∗∗p < 0.001 vs. EtOH group.
pro-inflammatory cytokines produced by mature macrophage
underlying ethanol exposure.
Effects of AA and Acute Ethanol
Challenge on the Sirt1 Pathway and the
Phosphorylation of LKB1, AMPK
and ACC
Sirtuin 1 is a longevity gene and regulates lipid homeostasis,
while lipid homeostasis the critical reasons in the development of
fatty liver caused by alcohol. As shown in Figure 5A, expressions
of Sirt1 in the cytoplasm and the nucleus were decreased by
ethanol challenge. AA pretreatment increased Sirt1 expressions
in the cytoplasm and the nucleus. Especially, single AA treatment
obviously increased Sirt1 in the cytoplasm and the nucleus, which
indicated that AA might be a potential Sirt1 agonist. AMPK
is a major regulator of lipid and glucose metabolism. Thus we
investigated whether the protective effect of AA was related with
AMPK activation and it’s upstream or downstream, such as LKB1
or ACC, against ethanol challenge. The results of western blot
revealed p-LKB1, p-AMPKα, p-AMPKβ, and p-ACC levels were
significantly decreased in the liver of ethanol group compared
with those of normal group, while AA pretreatment showed
obviously increased p-LKB1, p-AMPKα, p-AMPKβ, and p-ACC
levels when compared with ethanol group (Figures 5B–D).
Effects of AA and Acute Ethanol
Challenge on the LXRs Pathway, PPARα
and PPARγ Expressions
Liver X receptors regulate cholesterol metabolism and hepatic
fat metabolism. With ethanol challenge, LXRα and LXRβ mRNA
levels were significantly decreased compared to normal group,
and AA markedly reversed LXRα and LXRβ mRNA levels
(Figure 6A). PPARα and PPARγ are the members of the ligand-
activated nuclear receptor transcription factor superfamily, and
participate in lipogenesis, energy and glucose homeostasis.
As shown in Figure 6B, the protein levels of PPARα were
decreased by ethanol challenge compared with those of the
normal group. AA pretreatment restored the protein levels of
PPARα compared with those of ethanol group (Figure 6B).
Interestingly, ethanol challenge increased the protein levels of
PPARγ compared with normal group, while AA pretreatment
decreased the protein levels of PPARγ (Figure 6B). However, this
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FIGURE 8 | Acanthoic acid increases the LXRs activities and activates the Sirt1/LKB1/AMPK/ACC signaling pathways in EtOH/LPS stimulated
AML-12 cell. AML-12 cells were pretreated with AA (5, 10, 20 µM), or AICAR (500 µM), or GW3965 (1 µM), or SRT1720 (6 µM), or Nicotinamide (20 mM) for 2 h,
respectively, and then following treated with EtOH (200 mM) and LPS (10 ng/ml) for additional 48 h. (A) Representative western blot analysis of Sirt1, p-LKB1,
p-ACC, PPARα, and PPARγ was normalized based on the internal control β-actin. (B) Representative western blot analysis of p-AMPKα, p-AMPKβ, total AMPKα
and AMPKβ. (C) Representative western blot analysis of LXRα and LXRβ was normalized based on the internal control GAPDH. (D) Representative western blot
analysis of Sirt1, LXRα and LXRβ was normalized based on the internal control GAPDH. #p < 0.05, ##p < 0.01, ###p < 0.001 vs. normal group; ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001 vs. EtOH group.
result is similar with overexpression of PPARγ in hepatocytes
further leads to the development of lipogenic steatosis (Rull et al.,
2014).
AA Increases the LXRs Activities and
Activates the Sirt1/LKB1/AMPK/ACC
Signaling Pathways in EtOH/LPS
Stimulated AML-12 Cell
To clarify the relationship of SIRT1-LXR and LKB1/AMPK/ACC
signaling on the regulation of alcohol exposure-induced liver
lipid deposition and inflammation, we detected the relative
signaling proteins under AA treatment in EtOH/LPS activity
of HSCs. As in the animal experiments, ethanol challenge
induced release of pro-inflammatory cytokines; ethanol and LPS
were treatment in AML-12 cells to simulate ethanol-exposure
mice. Firstly, we detected the effects of ethanol (0–400 mM)
on the cell viability of AML-12 for 24 or 48 h (Figure 7A).
And ethanol (100, 200, and 400 mM) for 48 h significantly
decreased cell viability compared with that for 24 h. In
Figure 7B, the cell viability of AA on AML-12 for 6 h were
detected, and AA (0–25 µM) showed no significantly effects
on cell viability of AML-12. Thus, we selected AA (5, 10, and
20 µM) for 2 h and following with ethanol (200 mM)/LPS
(10 ng/ml) for 48 h to simulate animal experiments and
researched the relative signaling pathway. In Figures 7C–E,
TG, IL-1β, and tumor necrosis factor-α (TNF-α) levels in
AML-12 cell were increased by treatment of EtOH/LPS, and
reversed with AA treatment (10 and 20 µM for TG and TNF-
α levels; 5, 10, and 20 µM for IL-1β levels). Red-stained
lipid droplets in EtOH/LPS group were observed in oil red O
staining. However, no obvious fat droplets were presented in
AA treatment groups (Figure 7F). Expressions of SREBP-1 and
CYP2E1were significantly increased with EtOH/LPS treatment,
and AA decreased the expressions of SREBP-1 and CYP2E1
(Figure 7G).
In the signaling pathway, EtOH/LPS significantly decreased
Sirt1, p-LKB1, p-ACC, PPARα protein expressions, and
increased PPARγ protein expression, which were reversed
with AA treatment (Figure 8A). And the regulation of AA
on SIRT1-LXR and LKB1/AMPK/ACC signaling in AML-
12 cells were similar with those in mice model. In order
to verify the effects of AA on AMPK, LXRs, and Sirt1, we
compared the effects of AA and above signaling agonists
or inhibitor. In Figure 8B, AA increased p-AMPKα and
p-AMPKβ protein expression as similar to AICAR, an
agonist of AMPK. And AA also increased LXRα and LXRβ
protein expressions as similar to GW3965, an agonist of LXRs
(Figure 8C). AA increased Sirt1 protein expressions as similar
to SRT1720, an agonist of LXRs; while shown a negative
regulation compared with Nicotinamide, an inhibitor of LXRs
(Figure 8D).
The results in AML-12 cell demonstrated AA increased
Sirt1-LXRs and regulates LKB1/AMPK/ACC signaling to
ameliorate alcohol exposure-induced liver lipid deposition and
inflammation.
Frontiers in Pharmacology | www.frontiersin.org 9 March 2017 | Volume 8 | Article 134
fphar-08-00134 March 14, 2017 Time: 15:37 # 10
Yao et al. Acanthoic Acid Regulates ALD
FIGURE 9 | A schematic representation showing the partially prevention of AA against liver lipid deposition and inflammation induced by alcohol.
DISCUSSION
In current study, AA obviously ameliorated alcohol exposure-
induced liver lipid deposition and inflammation by decreasing
TG levels, SREBP-1 expressions, fats in liver tissue, IL-1 and
IL-18 levels and caspase-1 expressions. Moreover, in alcohol
exposure, LKB1/Sirt1/AMPK/ACC and LXRs pathways were
necessary for the inhibition of AA on lipid deposition and
inflammation. Therefore, the results supported a novel effect
of AA on regulation of fatty acid homeostasis via Sirt1
signaling pathway, which suggested that AA would be a
promising therapeutic agent for ameliorating the development
of ALD.
Alcoholic liver diseases have become a major public health
issue all over the world. Most people know that excessive drinking
is harmful for health. It’s a pity there still is an increasing
number of patients with ALD. Therefore, it’s very important
to seek a natural therapeutic drug with high efficiency and
low toxicity, and explore underlying mechanisms and potential
clinical utilities. In our previous study, AA showed a strong
hepatoprotective effect against hepatic injury and hepatic fibrosis
induced by D-GalN/LPS, acetaminophen, or carbon tetrachloride
(CCl4) (Nan et al., 2008; Wu et al., 2010; Bai et al., 2014).
We also found AA ameliorated hepatic fibrosis via regulation
LXRs pathway. AA is considered as a potent activator of liver X
receptors (LXRα and LXRβ) targeting the cholesterol transporters
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(Jung et al., 2007). While LXRs play important roles in energy
homeostasis, and directly control hepatic cholesterol metabolic
regulations (Ghaddab-Zroud et al., 2014). In the current study,
we analyzed how LXR may crosstalk with other signaling
pathway during the regulation of AA on lipid deposition and
inflammation induced by alcohol exposure.
In the present study, AA increased the LXRs expressions
compared with ethanol exposure group. And activation of LXRs
by AA played an important role in lipid metabolism and anti-
inflammatory signaling, which was verified by tissue staining and
inflammatory markers. In vitro, AA showed the same function
with GW3965, a synthetic LXR agonist, and activated LXRs
expression. Thus, LXRs are considered as attractive targets in
treatment of AA on metabolic disease aiming for integration
of lipid metabolic and inflammatory. However, Sirt1 positively
regulates LXRs deacetylation. LXR acetylation is significant when
a single conserved lysine adjacent to activation domain, such
as K432 or K433 in LXRs. Sirt1 promotes deacetylation and
subsequent ubiquitination and interacts with LXR. Li et al. (2007)
found loss of Sirt1 reduced LXR targeting proteins involved in
lipid metabolism in vivo. Above information suggests that Sirt1 is
involved in regulation of AA on alcohol exposure-induced liver
lipid deposition and inflammation via LXRs signaling.
Sirtuin 1 regulates longevity effect leaded by the energy
restriction, and is known as a longevity gene (Shahedur
and Rezuanul, 2011). Sirt1 catalyzes Apurinic/apyrimidinic
endonuclease-1, enhances DNA base excision repair activity, and
generates a unique metabolite (Kim et al., 2016). Hepatic
metabolic derangements are the critical reasons in the
development of fatty liver caused by alcohol. Sirt1 regulates
lipid homeostasis by working with its substrate, such as
peroxisome proliferators-activated receptor α (PPARα), which
mediates fatty acid β-oxidation (Sharples et al., 2015). The
expression of PPARα positively correlates with the expression
of Sirt1 (Avila et al., 2016). In alcohol-exposure mice, we also
found AA enhanced hepatic Sirt1expression with increasing
PPARα expression. In the meantime, AA decreased SREBP-1
in protein and mRNA levels, CYP2E1 expression, and serum
and hepatic TG levels. SREBP-1 is the major transcription factor
regulating relative genes of hepatic fatty acid and TG synthesis,
and can up-regulate cytochrome p4502E1 (CYP2E1) expression
via free fatty acids, further control hepatic lipid oxidative stress
and lipid peroxidation. Over expression of CYP2E1 increases
lipid deposition and inflammation, and fat metabolism disorder.
Therefore, activation of Sirt1 by AA may be important for
the prevention of metabolic derangements caused by alcohol
exposure.
Accumulating studies have shown that AMP-activated protein
kinase (AMPK) is considered as a central regulator on
lipid metabolism and glucose homeostasis. Activated AMPK
inhibits fatty acid synthesis and stimulates energy-producing
pathways (Dagon et al., 2016). Synergistically activations of
AMPK and Sirt1 play key roles in insulin sensitivity and
glycemic control (Banerjee et al., 2016). LKB1, the upstream
AMPK-kinase, undertakes cellular kinase activity of AMPK via
phosphorylation and then the following downstream substrates
(Hardie et al., 2012). However, LKB1 is deacetylated on lysine
48 by Sirt1, and migrates from the nucleus to cytoplasm,
then leading to activation (Yang et al., 2014). Generally, Sirt1-
dependent activation of LKB1 simulates AMPK activation by
phosphorylation and establishes the Sirt1-LKB1-AMPK signaling
axis (Lan et al., 2008). AMPK also function the upstream of
Sirt1, and stimulate Sirt1 activity via NAD+ level (Cantó et al.,
2009). The crosstalk of Sirt1 and AMPK present in a bidirectional
positive-feedback, and follow with amplified stimulation for
downstream signaling. We observed the activation of Sirt1 and
LXRs by AA involves the upregulation of LKB1/AMPK/ACC
signaling pathways. With activation of Sirt1 and LXRs, AA
supplementation reversed p-LKB1, p-AMPK, and p-ACC levels
decreased by alcohol administration, which inhibits SREBP-1
and regulates fatty acid synthesis. A number of studies have
demonstrated that acute or chronic alcohol increases SREBP-1,
accumulates TG, and reduces fatty acid oxidation. The present
study strongly implicated AA as a potent agonist of Sirt1-LXRs
activation in alcohol exposure-induced liver lipid deposition and
inflammation.
Alcoholic liver diseases generally progress with inflammation
of liver (Cannon et al., 2016). Our study found F4/80, a mature
macrophage marker, was observed with ethanol challenge.
IL-1β and caspase-1 protein and mRNA expressions were
also increased with ethanol challenge. While AA treatment
significantly inhibited the expressions of F4/80, protein and
mRNA expressions of IL-1β and caspase-1.These results
indicated that ethanol challenge resulted in inflammation in
the liver of mice. AA pretreatment significantly reversed these
inflammation expressions, which demonstrated that AA could
regulate inflammation caused by ethanol challenge.
Given the effect of AA on the expression of Sirt1-LXRs
and regulation of LKB1/AMPK/ACC, we concluded that AA
increased Sirt1-LXRs, PPARα, reduced SREBP-1, CYP2E1 and
PPARγ, cleaved caspase-1 induction, and consequently reduced
IL-1β and increased IL-18 secretion through LKB1/AMPK/ACC
pathways in alcohol-induced lipid deposition and inflammation
(Figure 9). The study suggested that AA would provide
a preventive therapeutic candidate for lipid deposition and
inflammation in ALD and show advantages for potential clinical
applications.
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